CCEL,Cryo-Cell International, Inc. | Healthcare

Healthcare

CCEL

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Cryo-Cell International, Inc.CCEL

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use.

It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases.

The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells.

It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.

The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Latest News >

Market Chatter: Nippon Steel Seeks to Finalize $15 Billion US Steel Deal by Year-End

Nov 9, 2024

11:18 AM EST, 11/07/2024 (MT Newswires) -- Nippon Steel continues to anticipate closing its $15 billion acquisition of United States Steel ( X ) by year-end, aiming to sidestep any potential opposition once President-elect Donald Trump returns to the White House in January, Reuters reported Thursday, citing Nippon Steel's Vice Chairman Takahiro Mori. The transaction, which Nippon Steel considers essential...

National Bank Reviews Manulife Financial's Q3

Nov 9, 2024

11:56 AM EST, 11/07/2024 (MT Newswires) -- Manulife Financial's ( MFC ) third quarter results exceeded expectations on the back of strong Asia and WAM segment growth (and equally strong sales performance), notes National Bank. Analyst Gabriel Dechaine says these businesses are critical drivers for the lifeco to achieve its 18% ROE by 2027 target. Separately, the company executed on...

Ralph Lauren Soars As Q2 Results Outpace Expectations—CEO Eyes Holiday Season With Raised Revenue Goals

Nov 9, 2024

Ralph Lauren Corporation ( RL ) shares surged after the company reported better-than-expected second-quarter results. Quarterly adjusted earnings per share of $2.54, topped the consensus of $2.41. Quarterly revenues of $1.726 billion beat the street view of $1.677 billion. Revenue grew 6% YoY on a reported basis and rose 6% in constant currency. Foreign currency contributed 10 basis points to...

Tapestry Stock Jumps On Q3 Earnings Beat, Strong Sales, Raised Guidance

Nov 9, 2024

Tapestry, Inc ( TPR ). reported its fiscal 2025 first-quarter financial results on Thursday before the market opened. Here’s what you need to know. What To Know: Tapestry posted adjusted earnings per share of $1.02, beating the consensus estimate of 95 cents, according to Benzinga Pro. The Coach and Kate Spade parent company reported revenue of $1.51 billion, beating estimates...